A controlled human infection model of Streptococcus pyogenes pharyngitis (CHIVAS-M75): an observational, dose-finding study - The Lancet Microbe
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats - ScienceDirect
LEA29Y phase II dose-finding study design. | Download Scientific Diagram
AN OVERVIEW ON CLINICAL TRIALS - PharmaState Academy
How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text
Design of study A4001031. S1, Stage 1: Intensive PK/dose finding (4-12... | Download Scientific Diagram
Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4–5 December 2014) - Musuamba - 2017 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library
JCM | Free Full-Text | An Adequate Infusion Rate of Remimazolam for Induction of General Anesthesia in Adult Patients: A Prospective Up-and-Down Dose-Finding Study
Time to rethink dose-finding study design | Nature Reviews Drug Discovery
How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text
A Safety and Dose-finding Study of JNJ-26483327, a Drug in Development for Cancer, for
From Bench to Clinic - The Chronology of Preclinical Studies - ITR Laboratories Canada Inc.
Formoterol Fumarate Novel MDI Dose Range | Journal of COPD Foundation
How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text
View Image
EXPAND: A Phase Ib Dose-Finding Study of Ruxolitinib in Patients with Myelofibrosis and Low Platelet Counts | Research To Practice
PHASE I/II CLINICAL TRIAL DESIGN AND DOSE FINDING (PART I)
Efficient dose-finding for drug combination studies involving a shift in study populations - ScienceDirect
Figure 1 from Phase I Dose-Finding Study of OPB-111077, a Novel STAT3 Inhibitor, in Patients with Advanced Hepatocellular Carcinoma | Semantic Scholar
Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study - The
Preclinical IV busulfan dose-finding study to induce reversible myeloablation in a non-human primate model | PLOS ONE
First dose-ranging study demonstrating the dose-response relationship... | Download Scientific Diagram
Dose Finding in the Clinical Development of 60 US Food and Drug Administration–Approved Drugs Compared With Learning vs. Confirming Recommendations - Lyauk - 2019 - Clinical and Translational Science - Wiley Online Library
Dose Finding in the Clinical Development of 60 US Food and Drug Administration–Approved Drugs Compared With Learning vs. Confirming Recommendations - Lyauk - 2019 - Clinical and Translational Science - Wiley Online Library
How to design a dose-finding study on combined agents: Choice of design and development of R functions | PLOS ONE
Emerging Methods for Oncology Clinical Trials | CHANCE
Dose-finding trials: why not to use algorithmic designs
